- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
Results
7
Companies which are potentially undervalued and in an acceptable financial position.
7 companies
Dong-A Socio Holdings
Market Cap: ₩527.7b
Engages in the pharmaceutical business in South Korea.
A000640
₩78,900.00
7D
-7.0%
1Y
-29.4%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩253,000.00
7D
2.0%
1Y
-30.1%
Dong-A ST
Market Cap: ₩328.7b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩34,650.00
7D
-4.8%
1Y
-22.8%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩114,300.00
7D
-4.9%
1Y
-24.7%
PharmaResearch
Market Cap: ₩3.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩293,500.00
7D
-3.3%
1Y
-40.1%
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩85,500.00
7D
-5.2%
1Y
-5.9%
ST PharmLtd
Market Cap: ₩2.5t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩118,500.00
7D
-4.3%
1Y
51.3%